RCBTB1

Chr 13AR

RCC1 and BTB domain containing protein 1

Also known as: CLLD7, CLLL7, GLP, RDEOA

This protein contains an RCC1 domain and BTB domain and may be involved in cell cycle regulation through chromatin remodeling. Mutations cause autosomal recessive retinal dystrophy with or without extraocular anomalies. The gene shows minimal constraint against loss-of-function variants in population databases.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Retinal dystrophy with or without extraocular anomaliesMIM #617175
AR
0
Active trials
6
Pubs (1 yr)
84
P/LP submissions
6%
P/LP missense
0.79
LOEUF
LOF
Mechanism· G2P
Clinical SummaryRCBTB1
🧬
Gene-Disease Validity (ClinGen)
RCBTB1-related retinopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
69 unique Pathogenic / Likely Pathogenic· 209 VUS of 500 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.79LOEUF
pLI 0.000
Z-score 2.39
OE 0.51 (0.340.79)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.03Z-score
OE missense 0.83 (0.750.92)
245 obs / 294.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.51 (0.340.79)
00.351.4
Missense OE0.83 (0.750.92)
00.61.4
Synonymous OE0.96
01.21.6
LoF obs/exp: 14 / 27.6Missense obs/exp: 245 / 294.8Syn Z: 0.33
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongRCBTB1-related retinal dystrophy with or without extraocular anomaliesLOFAR
limitedRCBTB1-related familial exudative vitreoretinopathyOTHERAD
DN
0.7033th %ile
GOF
0.6442th %ile
LOF
0.3260th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic51
Likely Pathogenic18
VUS209
Likely Benign155
Benign49
Conflicting2
51
Pathogenic
18
Likely Pathogenic
209
VUS
155
Likely Benign
49
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
9
1
41
0
51
Likely Pathogenic
12
3
3
0
18
VUS
2
176
28
3
209
Likely Benign
2
3
62
88
155
Benign
0
2
33
14
49
Conflicting
2
Total25185167105484

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RCBTB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC